Zobrazeno 1 - 10
of 185
pro vyhledávání: '"Rie, Yamazaki"'
Autor:
Rie Yamazaki1, Midori Koshikawa2, Yuuki Fujinuma2, Risa Inagaki2, Takako Kamioka2, Seiko Sakai2, Aki Ooishi2, Tasuke Ito2, Noriyuki Hirabayashi2, Hiroko Matsuhashi1, Yasuhiro Igarashi1, Ryuji Tanosaki2
Publikováno v:
Japanese Journal of Transfusion & Cell Therapy / Nihon Yuketsu Saibo Chiryo Gakkaishi. 2024, Vol. 70 Issue 4, p499-501. 3p.
Autor:
Rie Yamazaki, Tomoe Uemura, Yasuhiro Igarashi, Hiroko Matsuhashi, Ayako Toriumi, Yumiko Asao, Rui Kuroda, Ryosuke Fujimura, Yuko Iyanaga, Jun Kato, Haruko Shima, Noriyuki Hirabayashi, Keisuke Kataoka, Ryuji Tanosaki
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 69:8-14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3df191734294e64a280496e89530b6fe
https://doi.org/10.3925/jjtc.69.8
https://doi.org/10.3925/jjtc.69.8
Autor:
Daigo Ochiai, Yushi Abe, Rie Yamazaki, Tomoe Uemura, Ayako Toriumi, Hiroko Matsuhashi, Yuya Tanaka, Satoru Ikenoue, Yoshifumi Kasuga, Ryuji Tanosaki, Mamoru Tanaka
Publikováno v:
Medicina, Vol 57, Iss 9, p 983 (2021)
Background and objectives: Massive postpartum hemorrhage (PPH) is the most common cause of maternal death worldwide. A massive transfusion protocol (MTP) may be used to provide significant benefits in the management of PPH; however, only a limited nu
Externí odkaz:
https://doaj.org/article/11652f295bd64e848801280be872ea55
Autor:
Kosei Nakajima, Yoshinori Ino, Rie Yamazaki-Itoh, Chie Naito, Mari Shimasaki, Mami Takahashi, Minoru Esaki, Satoshi Nara, Yoji Kishi, Kazuaki Shimada, Nobuyoshi Hiraoka
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
There is an increasing unmet need for successful immunotherapeutic interventions. Lymphocyte extravasation via tumor tissue endothelial cells (TECs) is required for lymphocyte infiltration into tumor sites. This study aimed to investigate the clinica
Externí odkaz:
https://doaj.org/article/731bbf5e20ec4d188f1e417bb9244abe
Autor:
Kimikazu Yakushijin, Satoshi Yoshihara, Junko Ikemoto, Kazuhiko Ikeda, Akaru Ishida, Hitoshi Ohto, Akira Ohara, Michiko Kajiwara, Atsushi Kikuta, Kyoko Haraguchi, Shin-ichiro Fujiwara, Minami Yamada-Fujiwara, Rie Yamazaki, Tokiko Nagamura-Inoue, Ryuji Tanosaki, Yoshiki Okuyama, Yoshihiro Fujimori, Yasunori Ueda
Publikováno v:
Japanese Journal of Transfusion & Cell Therapy / Nihon Yuketsu Saibo Chiryo Gakkaishi; 2023, Vol. 69 Issue 6, p641-647, 7p
Autor:
Kuwahara, Rie Yamazaki, Yamagishi, Hodaka, Hashimoto, Kumi, Tamesue, Shingo, Yamauchi, Takeshi, Tsubokawa, Norio
Publikováno v:
In Polymer 20 March 2015 61:99-107
Autor:
Kazuhiko Ikeda, Keiji Minakawa, Kenichi Yamahara, Minami Yamada‐Fujiwara, Yoshiki Okuyama, Shin‐ichiro Fujiwara, Rie Yamazaki, Heiwa Kanamori, Tohru Iseki, Tokiko Nagamura‐Inoue, Kazuaki Kameda, Kazuhiro Nagai, Nobuharu Fujii, Takashi Ashida, Asao Hirose, Tsutomu Takahashi, Hitoshi Ohto, Koki Ueda, Ryuji Tanosaki
Publikováno v:
Transfusion. 62:1280-1288
The standard cryoprotectant for human cellular products is dimethyl sulfoxide (DMSO), which is associated with hematopoietic cell infusion-related adverse events (HCI-AEs) in hematopoietic stem cell transplantation including peripheral blood stem cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba916318d36c50c4cd410c691ba3897f
https://doi.org/10.1111/trf.16877
https://doi.org/10.1111/trf.16877
Risk factors for CAR‐T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan
Autor:
Tomoyasu Jo, Satoshi Yoshihara, Yoshiki Okuyama, Keiko Fujii, Tomoko Henzan, Kaoru Kahata, Rie Yamazaki, Wataru Takeda, Yoshihiro Umezawa, Kentaro Fukushima, Takashi Ashida, Minami Yamada‐Fujiwara, Ryo Hanajiri, Noboru Yonetani, Yuma Tada, Yuji Shimura, Hidekazu Nishikii, Norio Shiba, Naoya Mimura, Jun Ando, Takayuki Sato, Yasuhiro Nakashima, Junko Ikemoto, Keita Iwaki, Shin‐ichiro Fujiwara, Masaki Ri, Tokiko Nagamura‐Inoue, Ryuji Tanosaki, Yasuyuki Arai
Publikováno v:
British Journal of Haematology.
For successful chimeric antigen receptor T (CAR-T) cell therapy, CAR-T cells must be manufactured without failure caused by suboptimal expansion. In order to determine risk factors for CAR-T cell manufacturing failure, we performed a nationwide cohor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4510dea0235b034671841fcea67d60e4
https://doi.org/10.1111/bjh.18831
https://doi.org/10.1111/bjh.18831
Autor:
Yuta Yokoyama, Eiji Nozawa, Miho Morita, Emi Ishikawa, Takehiko Mori, Masatoshi Sakurai, Taku Kikuchi, Eri Matsuki, Rie Yamazaki, Keisuke Kataoka, Aya Jibiki, Hitoshi Kawazoe, Sayo Suzuki, Tomonori Nakamura
Publikováno v:
Journal of Clinical Laboratory Analysis. 36
Dasatinib, nilotinib, and bosutinib, second-generation tyrosine kinase inhibitors (TKIs), and ponatinib, a third-generation TKI, are approved pharmaceuticals used in the treatment of chronic myeloid leukemia (CML). Although liquid chromatography-tand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::989402a6ffb51b97c0bf4b147c26ccf2
https://doi.org/10.1002/jcla.24598
https://doi.org/10.1002/jcla.24598
Autor:
Rie Yamazaki, Yohei Tomita, Taku Kikuchi, Miki Koh, Masuho Saburi, Sumiko Kohashi, Yoko Ozawa, Jun Kato, Masatoshi Sakurai, Yuya Koda, Ryohei Abe, Takehiko Mori
Publikováno v:
Bone Marrow Transplantation. 56:1266-1271
Although cytomegalovirus (CMV) remains a leading cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT), the incidence of CMV retinitis is considered to be lower than the incidence of CMV infection in other o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ad7a8337f2d97636f1717bba4fd0c48
https://doi.org/10.1038/s41409-020-01176-8
https://doi.org/10.1038/s41409-020-01176-8